Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2019-06-14 Regulatory Filings
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 13, 2019. It announces the adjournment and rescheduling of the 2019 Annual Meeting of Stockholders due to lack of quorum. The document includes a press release as an exhibit. The content is an announcement of an event related to the Annual General Meeting but does not contain the AGM materials or minutes themselves. The document length is 3565 characters, which is relatively short and primarily serves as a notification. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit the specific AGM Information (AGM-R) category, which would require actual AGM materials or presentations. The document is not a report publication announcement since it does not mention the release of a report but rather an event update.
2019-06-14 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the resignation of the Chief Financial Officer and the appointment of a new CFO, including biographical information and the consulting agreement. There are no financial statements or detailed financial performance data included. The document focuses on management changes, which aligns with announcements about changes in the company's board or senior management. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length (6703 characters) is sufficient to contain substantive information, not just a brief announcement or certification, supporting this classification with high confidence.
2019-06-04 English
Regulatory Filings 2019
Regulatory Filings
2019-05-24 English
8-K
Delisting Announcement Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 20, 2019, by NanoVibronix, Inc. The content focuses on a notice regarding the Nasdaq Listing Qualifications Panel's decision to continue the company's listing on the Nasdaq Stock Market, subject to compliance conditions and reporting requirements. This is a regulatory announcement about the company's listing status and compliance plan, not a full financial report or earnings release. The document is about a delisting-related matter but does not announce an actual delisting; rather, it discusses continued listing with conditions. Therefore, the most appropriate classification is a Delisting Announcement (DLST) as it pertains to listing status and compliance with listing rules.
2019-05-22 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from NanoVibronix, Inc. to the SEC Division of Corporation Finance regarding a Registration Statement on Form S-3 initially filed on December 31, 2018. The letter requests acceleration of the effective date of the registration statement. The content is a correspondence related to a regulatory filing process, specifically about the registration statement effectiveness, and does not contain financial data, report content, or detailed disclosures. The document length is short (3050 characters) and is clearly a communication or request rather than a report or financial statement. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and correspondence with the SEC.
2019-05-21 English
FORM 10-Q
Interim / Quarterly Report Q1 2019
2019-05-20 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.